Intervention

Budesonide/Formoterol

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions3

Lead sponsors shown4

Clinical trials

5 shown

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaNCT06676319 · 2024-11-07

ACTIVE_NOT_RECRUITING

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02345161 · 2015-01-23

Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaNCT01070888 · 2010-02-01

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaNCT00255255 · 2005-11-01

Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsNCT00252785 · 2005-10-01

Common conditions

Asthma3 Exercise Induced Asthma1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

AstraZeneca2 Boston Children's Hospital1 GlaxoSmithKline1 Sanofi1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING1

TERMINATED1

Phase mix

PHASE33

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.